English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksSell Dr Reddys Laboratories; target of Rs 1120: Deven Choksey

    Sell Dr Reddys Laboratories; target of Rs 1120: Deven Choksey

    Deven Choksey is bearish on Dr Reddys Laboratories has recommended sell rating on the stock with a target price of Rs 1120 in its research report dated July 29, 2025.

    Broker Research
    July 30, 2025 / 11:01 IST
    sell

    sell

     
     
    live
    • bselive
    • nselive
    Volume
    Todays L/H
    More

    Deven Choksey's research report on Dr Reddys Laboratories

    For Q1FY26, the revenue increased by 11.4% YoY (+0.5% QoQ) to INR 85,721 Mn, below our estimates by 3.0%, led by weakness in North America, which was partially offset by higher momentum across Europe and the Emerging markets. Double-digit revenue growth was driven by growth across all geographies, except North America.

    Outlook

    We downgrade our rating from “ACCUMULATE” to “SELL” on the stock, driven by the decline in EBITDA margin led by consistent price erosions and weaker gross margins.

    For all recommendations report, click here

    Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Dr Reddys Laboratories - 29072025 - deven

    Broker Research
    first published: Jul 30, 2025 11:01 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347